Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.
Cardiac resynchronization has emerged as a highly effective therapy for heart failure. However, up to 40% of patients do not benefit from this treatment. In this Review, we discuss the potential role of MRI and nuclear molecular imaging in providing additional insights into the response to cardiac resynchronization therapy. Variables with potential prognostic and therapeutic values include the evaluation of cardiac dyssynchrony, scar, cardiac sympathetic function, myocardial blood flow, myocardial glucose and oxidative metabolism. Other molecular targets to characterize apoptosis, fatty acid metabolism, angiogenesis and angiotensin-converting enzyme activity will also be described. The potential use of these techniques in identifying and measuring responses to cardiac resynchronization therapy and future areas of research will be explored.
Aggarwal
Niti R
NR
The Department of Internal Medicine Mayo Clinic, Rochester, MN, USA.
Martinez
Matthew W
MW
Gersh
Bernard J
BJ
Chareonthaitawee
Panithaya
P
D015415:Biomarkers / Q000378:metabolism; D002304:Cardiac Pacing, Artificial; D055426:Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; D005355:Fibrosis; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008279:Magnetic Resonance Imaging; D055414:Myocardial Perfusion Imaging / Q000379:methods*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D011237:Predictive Value of Tests; D011875:Radionuclide Angiography; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014022:Tissue Survival; D016896:Treatment Outcome; D016277:Ventricular Function, Left
D015415:Biomarkers